Preventive Effects of Dairy Products on Dementia and the Underlying Mechanisms

Preventive Effects of Dairy Products on Dementia and the Underlying Mechanisms

Alongside the rapid population aging occurring worldwide, the prevention of age-related memory decline and dementia has become a high priority. Dairy products have many physiological effects owing to their contents of lactic acid bacteria and the fatty acids and peptides generated during their ferme...

Full description

Bibliographic Details
Main Authors:	Yasuhisa Ano, Hiroyuki Nakayama
Format:	Article
Language:	English
Published:	MDPI AG 2018-06-01
Series:	International Journal of Molecular Sciences
Subjects:	amyloid β Alzheimer’s disease cognitive function dairy products dementia inflammation microglia
Online Access:	http://www.mdpi.com/1422-0067/19/7/1927

Similar Items

Preventive Effects of Tryptophan–Methionine Dipeptide on Neural Inflammation and Alzheimer’s Pathology
by: Yasuhisa Ano, et al.
Published: (2019-06-01)

Iso-α-Acids, Bitter Components in Beer, Suppress Inflammatory Responses and Attenuate Neural Hyperactivation in the Hippocampus
by: Yasuhisa Ano, et al.
Published: (2019-02-01)

Treadmill Exercise Decreases Aβ Deposition and Counteracts Cognitive Decline in APP/PS1 Mice, Possibly via Hippocampal Microglia Modifications
by: Xianliang Zhang, et al.
Published: (2019-04-01)

Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs
by: Devesh Tewari, et al.
Published: (2018-02-01)

The genetics of dementias. Part 2: The biology of Alzheimer’s disease
by: Anna Kowalska
Published: (2009-06-01)

Alzheimer’s disease as an inflammatory disease
by: Bolós Marta, et al.
Published: (2017-03-01)

Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer’s disease
by: Oskar Hansson, et al.
Published: (2019-10-01)

Cajaninstilbene Acid Ameliorates Cognitive Impairment Induced by Intrahippocampal Injection of Amyloid-β1–42 Oligomers
by: Li-Sha Wang, et al.
Published: (2019-09-01)

Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife
by: Minos Kritikos, et al.
Published: (2020-04-01)

The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
by: Rola Ismail, et al.
Published: (2020-05-01)

Neuroinflammation in Alzheimer's disease continuum
by: Aslihan Taskiran-Sag, et al.
Published: (2020-01-01)

Cross-sectional Associations of Fatigue with Cerebral β-Amyloid in Older Adults at Risk of Dementia
by: Claudie Hooper, et al.
Published: (2017-11-01)

Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer’s disease
by: Ceren Emre, et al.
Published: (2021-06-01)

Complex regulation of acute and chronic neuroinflammatory responses in mouse models deficient for nuclear factor kappa B p50 subunit
by: Taisia Rolova, et al.
Published: (2014-04-01)

Manganese Exposure Aggravates β-Amyloid Pathology by Microglial Activation
by: Geng Lin, et al.
Published: (2020-11-01)

Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2)
by: Li Zhong, et al.
Published: (2018-03-01)

Interplay Between Microglia and Alzheimer’s Disease—Focus on the Most Relevant Risks: APOE Genotype, Sex and Age
by: Yanting Chen, et al.
Published: (2021-04-01)

Galectin-3: a key player in microglia-mediated neuroinflammation and Alzheimer's disease
by: Yinyin Tan, et al.
Published: (2021-04-01)

β-Lactolin Reduces Age-Related Inflammation and Cognitive Decline
by: Yasuhisa Ano, et al.
Published: (2021-08-01)

Upregulation of MIF as a defense mechanism and a biomarker of Alzheimer’s disease
by: Si Zhang, et al.
Published: (2019-06-01)

Microglia function in Alzheimer’s disease
by: Egle eSolito, et al.
Published: (2012-02-01)

Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction
by: Jennifer L. Tomic, et al.
Published: (2009-09-01)

Microglial Heterogeneity and Its Potential Role in Driving Phenotypic Diversity of Alzheimer’s Disease
by: Stefano Sorrentino, et al.
Published: (2021-03-01)

Aging Reduces Estradiol Protection Against Neural but Not Metabolic Effects of Obesity in Female 3xTg-AD Mice
by: Amy Christensen, et al.
Published: (2020-05-01)

Influenza vaccination in early Alzheimer’s disease rescues amyloidosis and ameliorates cognitive deficits in APP/PS1 mice by inhibiting regulatory T cells
by: Yunjie Yang, et al.
Published: (2020-02-01)

Safety and Efficacy of Scanning Ultrasound Treatment of Aged APP23 Mice
by: Gerhard Leinenga, et al.
Published: (2018-02-01)

Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to β-amyloid deposition in APP/PS1 double transgenic Alzheimer mice
by: Tarja M. Malm, et al.
Published: (2005-02-01)

Clinical Impact of PET With 18F-FDG and 11C-PIB in Patients With Dementia in a Developing Country
by: Andres Damian, et al.
Published: (2021-05-01)

Editorial: Natural Products-Based Drugs: Potential Therapeutics Against Alzheimer’s Disease and Other Neurological Disorders
by: Muhammad Ayaz, et al.
Published: (2019-11-01)

Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer′s Disease
by: Ingrid H. C. H. M. Philippens, et al.
Published: (2021-04-01)

The Effects of Treadmill Exercise on Iron Accumulation and Microglia Activation in the Brain of APP-C105 Transgenic Mice of Alzheimer’s Disease
by: Joo-Young Lee, et al.
Published: (2019-11-01)

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
by: Inger van Steenoven, et al.
Published: (2019-10-01)

A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative Review
by: Ismael Conejero, et al.
Published: (2018-06-01)

Microglia in the Alzheimer's brain: a help or a hindrance?
by: Craig T. Vollert, et al.
Published: (2014-12-01)

Alzheimer's Disease The 21st Century Challenge
Published: (2018)

Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response
by: Anna A. Pimenova, et al.
Published: (2021-01-01)

Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease
by: Jiyoung Kim
Published: (2021-03-01)

Cepharanthine promotes the effect of dexmedetomidine on the deposition of β-amyloid in the old age of the senile dementia rat model by regulating inflammasome expression
by: Youhua Wu, et al.
Published: (2019-11-01)

Cerebrovascular medin is associated with Alzheimer's disease and vascular dementia
by: Raymond Q. Migrino, et al.
Published: (2020-01-01)

Elevated Expression of MiR-17 in Microglia of Alzheimer’s Disease Patients Abrogates Autophagy-Mediated Amyloid-β Degradation
by: Shady Estfanous, et al.
Published: (2021-07-01)